YOLFTbeta
60

Qingdao Vland Biotech Co Ltd

603739 · SHG · Healthcare / Biotechnology

11.45CNY-0.30 (-2.55%)

Price History

Full chart

Market Stats

Previous Close11.75
Open11.71
Day Range11.40 – 11.82
52-Week Range10.68 – 18.41
Volume3.23M
Market Cap3.55B
P/E (TTM)43.88
Forward P/E0.00
EPS0.32
Dividend Yield0.71%
Beta0.39
50-Day Avg12.35
200-Day Avg13.86

About

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, food probiotics, environmental microorganisms, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was founded in 2005 and is headquartered in Qingdao, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Gang Chen
  • Employees1.52K
  • HeadquartersNo. 596-1, Jiushui East Road, Qingdao, China, 266100, China
  • Websitehttps://www.vlandgroup.com

Leadership

  • Mr. Gang ChenGM & Chairman · b. 1975
  • Mr. Piyuan QiaoCFO & Director · b. 1977
  • Mr. Yong JiangBoard Secretary · b. 1980
  • Hailiang LiAccounting Supervisor

Financials

Income Statement

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue728.22M751.72M781.23M799.44M813.97M846.78M960.25M1.15B1.16B1.20B1.32B1.37B
Growth (%)-+3.23%+3.93%+2.33%+1.82%+4.03%+13.40%+19.85%+1.07%+3.07%+10.16%+3.43%
Cost of Revenue336.19M361.10M355.51M384.24M409.54M437.27M495.66M620.40M662.86M648.46M728.42M754.15M
Gross Profit392.03M390.62M425.72M415.20M404.43M409.50M464.59M530.43M500.30M550.44M592.34M611.97M
Gross Margin53.83%51.96%54.49%51.94%49.69%48.36%48.38%46.09%43.01%45.91%44.85%44.80%
Operating Expense345.43M322.18M331.04M300.08M295.44M311.71M322.52M359.56M397.40M427.54M468.32M477.90M
Operating Income46.60M68.44M94.68M115.12M108.99M97.79M142.06M170.87M102.90M122.90M124.02M134.07M
Operating Margin6.40%9.10%12.12%14.40%13.39%11.55%14.79%14.85%8.85%10.25%9.39%9.81%
EBITDA111.08M138.60M152.70M155.16M151.78M137.32M184.79M225.23M175.07M211.50M256.62M258.27M
EBITDA Margin15.25%18.44%19.55%19.41%18.65%16.22%19.24%19.57%15.05%17.64%19.43%18.91%
Net Income53.23M70.27M82.55M85.63M83.38M77.75M108.98M132.57M69.84M80.71M62.64M69.81M
Net Income Margin7.31%9.35%10.57%10.71%10.24%9.18%11.35%11.52%6.00%6.73%4.74%5.11%
R&D97.97M83.26M77.48M70.62M69.69M75.00M79.91M100.94M102.40M110.68M121.25M139.21M
R&D as % of Total Revenue13.45%11.08%9.92%8.83%8.56%8.86%8.32%8.77%8.80%9.23%9.18%10.19%
Interest Expense-6.65M4.71M3.03M4.82M2.29M2.71M2.67M9.15M15.22M22.77M18.00M
Interest Expense % of Total Revenue-0.88%0.60%0.38%0.59%0.27%0.28%0.23%0.79%1.27%1.72%1.32%

Balance Sheet

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets794.79M821.63M827.92M883.55M945.32M1.28B1.45B2.22B2.58B3.03B2.98B3.04B
Total Liabilities328.53M302.27M269.96M291.02M313.94M248.99M336.22M536.18M844.93M1.21B1.11B1.13B
Total Equity434.21M483.94M516.49M544.26M569.69M962.18M1.03B1.60B1.64B1.71B1.74B1.78B
Cash115.47M107.32M130.23M175.29M159.66M174.05M249.92M311.83M213.87M239.60M248.73M244.16M
Total Debt130.00M95.00M30.00M75.00M105.00M36.90M67.83M235.93M523.22M631.03M595.59M-
Net Debt14.53M-12.32M-100.23M-100.29M-54.66M-137.15M-182.09M-75.90M309.35M391.44M346.86M398.50M

Cash Flow

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow58.55M74.27M154.49M121.90M85.75M65.33M173.00M89.51M95.31M153.59M195.41M113.95M
Investing Cash Flow-21.11M-38.68M-10.88M-54.63M-70.41M-294.48M-95.73M-606.73M-428.17M-298.78M-42.46M-
Financing Cash Flow-30.19M-52.88M-114.71M-17.05M-28.51M243.11M-136.73K580.56M227.72M156.36M-141.47M-
Capital Expenditure50.93M55.32M26.55M58.05M71.56M120.17M211.83M493.58M342.02M215.64M104.72M80.01M
Free Cash Flow7.62M18.95M127.94M63.85M14.19M-54.84M-38.83M-404.06M-246.72M-62.05M90.69M33.94M
Dividends Paid51.98M27.74M53.93M60.55M62.35M30.93M30.93M36.01M40.33M39.77M55.23M43.01M
FCF to OCF13.01%25.52%82.81%52.38%16.54%-83.95%-22.45%-451.40%-258.87%-40.40%46.41%29.78%
Dividend Paid to FCF682.30%146.35%42.15%94.83%439.46%-56.40%-79.66%-8.91%-16.35%-64.09%60.91%126.73%

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 27, 2020Oct 30, 2020Dec 31, 2020Apr 20, 2021Aug 16, 2021Oct 28, 2021Dec 31, 2021Apr 19, 2022Aug 23, 2022Oct 28, 2022Dec 31, 2022Apr 26, 2023
EPS Estimate-----------------
EPS Actual0.050.100.070.140.100.100.130.170.130.130.130.150.070.080.070.060.06
Surprise-----------------
Timing----Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-market

Key Statistics & Ratios

Market Cap3.55B
Enterprise Value3.49B
Trailing P/E43.88
Forward P/E0.00
Price / Sales2.50
Price / Book1.84
EPS0.32
Book Value7.10
Revenue (TTM)1.42B
Gross Profit (TTM)622.34M
EBITDA200.72M
Profit Margin5.74%
Operating Margin8.05%
Return on Equity5.89%
Return on Assets1.79%
Shares Outstanding253.03M
Shares Float90.03M
Beta0.39
Dividend Yield0.71%
Dividend Rate0.10
Payout Ratio31.25%

Dividends

20231×
0.10May 31, 2023
20221×
0.16May 24, 2022
20211×
0.20May 25, 2021
20201×
0.14Jun 3, 2020
20191×
0.14May 29, 2019

Stock Splits

  • May 25, 20217:5